ABIOMED Inc
Change company Symbol lookup
Select an option...
ABMD ABIOMED Inc
TECK Teck Resources Ltd
BCBNF Base Carbon Inc
PAVM PAVmed Inc
HTGC Hercules Capital Inc
NRG NRG Energy Inc
NLTX Neoleukin Therapeutics Inc
AROW Arrow Financial Corp
EQ Equillium Inc
WSFS WSFS Financial Corp
Go

Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profile

ABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The Company's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.

Closing Price
$255.32
Day's Change
6.70 (2.69%)
Bid
--
Ask
--
B/A Size
--
Day's High
255.57
Day's Low
248.04
Volume
(Heavy Day)
Volume:
405,716

10-day average volume:
328,144
405,716

Company Profile

ABIOMED, Inc. is a medical technology provider, which provides circulatory support and oxygenation. The Company develops, manufactures and markets its products, which are designed to enable the heart to rest by improving blood flow and/or performing the pumping of the heart. Its products are used in the cardiac catheterization lab or cath lab, by interventional cardiologists and in the heart surgery suite by cardiac surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty, or heart surgery procedures. The Company's Impella device portfolio includes the Impella 2.5, Impella CP, Impella 5.0, Impella LD, Impella 5.5 and Impella RP devices. Its product pipeline includes Impella ECP, Impella XR Sheath, Impella BTR and precardiac. The Impella ECP device is designed for blood flow of greater than three and a half liters per minute. The Impella BTR device is designed to be a heart pump with integrated motors and sensors.

Valuation Ratios

Price/Earnings (TTM)
86.14x
Price/Sales (TTM)
11.28x
Price/Book (MRQ)
7.74x
Price/Cash Flow (TTM)
70.68x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

May 2022
Current Month
1.6M
Previous Month
1.5M
Percent of Float
3.67%
Days to Cover
4.1601 Days

Share Information

ABMD is in a share class of common stock
Float
44.6M
Shares Outstanding
45.6M
Institutions Holding Shares
777
92.61%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in thousands.

Company Officers

  • Michael R. MinogueChmn.
  • Todd A. TrappCFO
  • Marc A. BeganVP
  • Andrew J. GreenfieldVP
  • Dorothy E. Puhy

Address

Insider Trading

During the most recent quarter, 40K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.